$2.73T
Total marketcap
$106.95B
Total volume
BTC 50.56%     ETH 16.45%
Dominance

N4 Pharma Plc 0GO.F Stock

0.001 EUR {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
2.36M EUR
LOW - HIGH [24H]
0.0010 - 0.0010 EUR
VOLUME [24H]
600 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.01 EUR

N4 Pharma Plc Price Chart

N4 Pharma Plc 0GO.F Financial and Trading Overview

N4 Pharma Plc stock price 0.0010 EUR
Previous Close 0.01 EUR
Open 0.01 EUR
Bid 0.0095 EUR x N/A
Ask 0.04 EUR x N/A
Day's Range 0.01 - 0.01 EUR
52 Week Range 0.008 - 0.06 EUR
Volume 600 EUR
Avg. Volume 0 EUR
Market Cap 4.98M EUR
Beta (5Y Monthly) -0.108812
PE Ratio (TTM) N/A
EPS (TTM) -0.01 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

0GO.F Valuation Measures

Enterprise Value 652.05K EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.1111112
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

N4 Pharma Plc Stock Price History

Beta (5Y Monthly) -0.108812
52-Week Change -55.0000000000000071%
S&P500 52-Week Change 20.43%
52 Week High 0.06 EUR
52 Week Low 0.008 EUR
50-Day Moving Average 0.01 EUR
200-Day Moving Average 0.01 EUR

0GO.F Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 233.78M
Float 202.46M
Short Ratio N/A
% Held by Insiders 13.28%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -33.084%
Return on Equity (ttm) -48.80%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -1029261 EUR
Diluted EPS (ttm) -0.01
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.92M EUR
Total Cash Per Share (mrq) 0.008 EUR
Total Debt (mrq) 0 EUR
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 27.809
Book Value Per Share (mrq) 0.009

Cash Flow Statement

Operating Cash Flow (ttm) -828263 EUR
Levered Free Cash Flow (ttm) -544789 EUR

Profile of N4 Pharma Plc

Country Germany
State N/A
City London
Address 60 Gracechurch Street
ZIP EC3V 0HR
Phone 44 1332 690061
Website https://www.n4pharma.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 5

N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.

Q&A For N4 Pharma Plc Stock

What is a current 0GO.F stock price?

N4 Pharma Plc 0GO.F stock price today per share is 0.0010 EUR.

How to purchase N4 Pharma Plc stock?

You can buy 0GO.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for N4 Pharma Plc?

The stock symbol or ticker of N4 Pharma Plc is 0GO.F.

Which industry does the N4 Pharma Plc company belong to?

The N4 Pharma Plc industry is Drug Manufacturers-Specialty & Generic.

How many shares does N4 Pharma Plc have in circulation?

The max supply of N4 Pharma Plc shares is 2.36B.

What is N4 Pharma Plc Price to Earnings Ratio (PE Ratio)?

N4 Pharma Plc PE Ratio is now.

What was N4 Pharma Plc earnings per share over the trailing 12 months (TTM)?

N4 Pharma Plc EPS is -0.01 EUR over the trailing 12 months.

Which sector does the N4 Pharma Plc company belong to?

The N4 Pharma Plc sector is Healthcare.